NCT01692197 2018-07-03E7070, Idarubicin and Cytarabine in Relapsed AML and High-Risk Myelodysplastic SyndromesM.D. Anderson Cancer CenterPhase 2 Completed43 enrolled 11 charts
NCT02419755 2018-03-07Bortezomib and Vorinostat in Younger Patients With Refractory or Relapsed MLL Rearranged Hematologic MalignanciesSt. Jude Children's Research HospitalPhase 2 Terminated12 enrolled 10 charts